Cronos group - The Trending News

Web portal. Search, collect, analyze news, info & data from Internet by preview-urls.com

Top News Headlines

Reviewing Cronos Group Inc. (CRON)'s and Adverum Biotechnologies Inc. (NASDAQ:ADVM)'s results
As Biotechnology businesses, Cronos Group Inc. (NASDAQ:CRON) and Adverum Biotechnologies Inc. (NASDAQ:ADVM), are affected by compare.
Aug 15, 2019 22:24 UTC Read More

Reviewing Stemline Therapeutics Inc. (STML)'s and Cronos Group Inc. (NASDAQ:CRON)'s results
Stemline Therapeutics Inc. (NASDAQ:STML) and Cronos Group Inc. (NASDAQ:CRON) compete with each other in the Biotechnology sector. We will analyze…
Aug 15, 2019 10:06 UTC Read More

Comparison of Urovant Sciences Ltd. (UROV) and Cronos Group Inc. (NASDAQ:CRON)
As Biotechnology companies, Urovant Sciences Ltd. (NASDAQ:UROV) and Cronos Group Inc. (NASDAQ:CRON) are our subject to contrast. And more…
Aug 15, 2019 06:46 UTC Read More

Epizyme Inc. (EPZM) and Cronos Group Inc. (NASDAQ:CRON) Comparison side by side
As Biotechnology companies, Epizyme Inc. (NASDAQ:EPZM) and Cronos Group Inc. (NASDAQ:CRON) are our subject to contrast. And more specifically their…
Aug 14, 2019 20:35 UTC Read More

Comparison of Genmab A/S (GMAB) and Cronos Group Inc. (NASDAQ:CRON)
We are contrasting Genmab A/S (NASDAQ:GMAB) and Cronos Group Inc. (NASDAQ:CRON) on their institutional ownership, analyst recommendations,…
Aug 14, 2019 15:12 UTC Read More

Contrasting of Cronos Group Inc. (CRON) and Aimmune Therapeutics Inc. (NASDAQ:AIMT)
Both Cronos Group Inc. (NASDAQ:CRON) and Aimmune Therapeutics Inc. (NASDAQ:AIMT) compete on a level playing field in the Biotechnology industry.
Aug 14, 2019 02:18 UTC Read More

Cronos Group Inc. (CRON)'s Financial Results Comparing With Autolus Therapeutics plc (NASDAQ:AUTL)
As Biotechnology companies, Cronos Group Inc. (NASDAQ:CRON) and Autolus Therapeutics plc (NASDAQ:AUTL) are our subject to compare. And more…
Aug 13, 2019 04:46 UTC Read More

Reviewing Cyclerion Therapeutics Inc. (CYCN)'s and Cronos Group Inc. (NASDAQ:CRON)'s results
We will be comparing the differences between Cyclerion Therapeutics Inc. (NASDAQ:CYCN) and Cronos Group Inc. (NASDAQ:CRON) as far as analyst…
Aug 12, 2019 17:40 UTC Read More

Cronos Group Inc (CRON) Chaikin Money Flow Showing Negative Signs
Cronos Group Inc (CRON) is seeing negative money flow as the Chalkin (CMF) indicator is holding below the zero line. The Chaikin Money Flow Indicator is an…
Aug 12, 2019 13:50 UTC Read More

Cronos Group (NASDAQ:CRON) Rating Increased to Buy at Zacks Investment Research
Zacks Investment Research upgraded shares of Cronos Group (NASDAQ:CRON) from a hold rating to a buy rating in a research note published on Friday,…
Aug 12, 2019 11:37 UTC Read More

Brokerages Anticipate Cronos Group Inc (NASDAQ:CRON) to Announce $0.02 Earnings Per Share
Equities research analysts expect Cronos Group Inc (NASDAQ:CRON) to report ($0.02) earnings per share for the current quarter, according to Zacks Investment…
Aug 12, 2019 04:51 UTC Read More

Hub Group, Inc. (NasdaqGS:HUBG), Cronos Group Inc. (TSX:CRON): Price to Cash Flow Under Review
In order to determine if a company is fairly valued, we can look at a number of different ratios and metrics. First off we'll take a look at the Price to.
Aug 11, 2019 17:10 UTC Read More

Cronos Group Inc (NASDAQ:CRON) Shares Bought by Flagship Harbor Advisors LLC
Flagship Harbor Advisors LLC grew its holdings in Cronos Group Inc (NASDAQ:CRON) by 290.2% in the second quarter, according to its most recent disclosure…
Aug 11, 2019 16:52 UTC Read More

Cronos Group Inc. (TSX:CRON) 0.006276 Earnings Yield According to Quant
Earnings Yield is calculated by taking the operating income or earnings before interest and taxes (EBIT) and dividing it by the Enterprise Value of the company.
Aug 11, 2019 16:35 UTC Read More

Cronos Group (NASDAQ:CRON) Upgraded to Buy by Zacks Investment Research
Cronos Group (NASDAQ:CRON) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Friday,…
Aug 11, 2019 12:32 UTC Read More

Cronos Group (NASDAQ:CRON) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS
Cronos Group (NASDAQ:CRON) announced its quarterly earnings results on Thursday. The company reported ($0.01) earnings per share (EPS) for the quarter,…
Aug 11, 2019 11:23 UTC Read More

Cronos Group (TSE:CRON) Upgraded at Canaccord Genuity
Cronos Group (TSE:CRON) was upgraded by equities research analysts at Canaccord Genuity from a “sell” rating to a “hold” rating in a research report issued to…
Aug 11, 2019 10:52 UTC Read More

AE Wealth Management LLC Has $254,000 Holdings in Cronos Group Inc (NASDAQ:CRON)
AE Wealth Management LLC boosted its holdings in shares of Cronos Group Inc (NASDAQ:CRON) by 9.7% in the second quarter, according to its most recent…
Aug 10, 2019 13:36 UTC Read More

Cronos Group Inc (TSE:CRON) Given Consensus Rating of “Hold” by Brokerages
Shares of Cronos Group Inc (TSE:CRON) have been given a consensus recommendation of “Hold” by the eight ratings firms that are currently covering the stock,…
Aug 10, 2019 05:13 UTC Read More

Cronos Group Inc (CRON.TO) Shares Churn Downward 21.39% For the Quarter
Cronos Group Inc (CRON.TO) have moved lower over the course of the past few months revealing negative downward momentum for the shares as they have.
Aug 10, 2019 02:30 UTC Read More

Cronos Group Inc. (:CRON) Is on a Path to $15.04 According to Analysts
Investors might be trying to gauge which way shares of Cronos Group Inc. (:CRON) will swing over the next couple of quarters. In recent trading activity, the stock…
Aug 09, 2019 19:16 UTC Read More

Analysts Set Cronos Group Inc (NASDAQ:CRON) Price Target at $19.49
Shares of Cronos Group Inc (NASDAQ:CRON) have been given a consensus rating of “Hold” by the fifteen ratings firms that are covering the firm, Marketbeat…
Aug 09, 2019 13:24 UTC Read More

Cronos Group Inc (NASDAQ:CRON) Receives $19.49 Average Target Price from Brokerages
Shares of Cronos Group Inc (NASDAQ:CRON) have been given an average recommendation of “Hold” by the fifteen research firms that are currently covering…
Aug 09, 2019 13:22 UTC Read More

Cookies

We may use cookies to give you the best experience. If you do nothing we'll assume that it's ok.

Terms & Privacy

The information forward from this site may be provided by third parties. We will not be responsible with outside links, contents from source of information, methods of using, using or consequence of contents with users. All direct or indirect risk related to use of this site is borne entirely by you, the user.

We use advertising companies as Google AdSense, to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, see https://policies.google.com/technologies/ads.